NovoTTF-100A system is FDA approved for Glioblastoma - 19-Apr-2011

FDA recently approved the NovoTTF-100A System, a new device from Novocure Inc. to treat adults with glioblastoma multiforme (GBM) that recurs or progresses after receiving chemotherapy and radiation therapy.

Related News

Related Oncology Information

Related Oncology Drugs

Back to top

Latest News

10 May 2015
23 May 2013
22 May 2013